Clinical Correlation & Management: Complex Diabetic Patient

Patient Summary (Lab & Clinical Interpretation)

Clinical Correlation: How Everything Ties Together

1. The Central Problem — Uncontrolled T2DM with DKA

"The three fundamental biochemical features of diabetic ketoacidosis are hyperglycemia (or a history of diabetes), urinary ketone levels ≥2+ or ≥3.0 mmol/L, and arterial/venous pH <7.3."

2. Symptoms Explained Pathophysiologically

3. ECG Findings — LVH + Lateral ST Changes

• LVH: Consequence of long-standing hypertension often accompanying uncontrolled T2DM. As Braunwald's Heart Disease notes, increased QRS voltage with history of hypertension is a classic LVH pattern.
• Lateral ST changes / ischemia signs: In the context of DKA, this represents type 2 myocardial infarction (demand ischemia) — the metabolic crisis (acidosis, tachycardia, hyperosmolality, electrolyte shifts) dramatically increases myocardial oxygen demand while reducing supply.
• Troponin negative, CK-MB 22 (borderline elevated): This is consistent with myocardial stress without frank MI. The mildly elevated CK-MB may also reflect some skeletal muscle breakdown (rhabdomyolysis risk in DKA).

Important: Rosen's Emergency Medicine lists acute coronary syndrome as a precipitant of DKA — bidirectional relationship. The ischemic ECG must be monitored with serial troponins (at 3h and 6h) to rule out delayed troponin rise.

4. Elevated SGOT (60 U/L)

• Mild SGOT elevation in uncontrolled T2DM typically reflects non-alcoholic fatty liver disease (NAFLD) or metabolic hepatopathy — fat accumulation in hepatocytes due to chronic insulin resistance and lipid dysregulation in DKA.
• Also: SGOT can rise with rhabdomyolysis or myocardial stress.
• LFT otherwise clear — no hepatitis, no cholestasis.

5. Normal KFT — A Relative Reassurance

Treatment Plan

PRIORITY 1 — DKA Management (Immediate)

• Normal saline (0.9% NaCl) 1 litre over the first hour IV
• Subsequent rate: 250–500 mL/hour, adjusted to clinical response
• Switch to 0.45% NaCl once serum Na corrects
• Add dextrose when blood glucose drops to ~200 mg/dL (prevents hypoglycemia while insulin continues)

• Regular insulin IV infusion: 0.1 units/kg/hour (after initial bolus 0.1 units/kg IV if patient is not hypokalemic)
• Target: reduce glucose by 50–70 mg/dL per hour
• Do NOT start insulin if K⁺ <3.5 mEq/L — replace potassium first

• Critical: DKA depletes total body potassium even if serum K⁺ appears normal/high initially
• Add KCl 20–40 mEq/L to IV fluids once urine output confirmed and K⁺ <5.5 mEq/L
• Target K⁺: 3.5–5.0 mEq/L throughout insulin infusion

• Consider only if pH <6.9 or severe acidosis causing hemodynamic compromise
• Not routinely indicated for moderate DKA

• Blood glucose every 1 hour
• Electrolytes, ABG, ketones every 2–4 hours
• Urine output hourly (Foley catheter)

PRIORITY 2 — Cardiac Monitoring & Ischemia Management

• Serial ECGs every 4–6 hours
• Serial troponin at 3h and 6h (rule out evolving NSTEMI — troponin may rise later)
• Continuous cardiac monitoring (telemetry): DKA causes QTc prolongation and arrhythmia risk from electrolyte abnormalities
• Avoid aggressive tachycardia — treat underlying metabolic crisis
• If troponin rises on serial testing, initiate ACS protocol (aspirin, heparin, cardiology consult)
• Echocardiogram electively to assess LV function and degree of hypertrophy

PRIORITY 3 — Acute Bronchitis (Precipitating Infection)

• CRP 7.29 suggests ongoing inflammation/infection
• In a diabetic patient, what begins as bronchitis can evolve to pneumonia — obtain chest X-ray
• If bacterial superinfection: Broad-spectrum antibiotics (e.g., Amoxicillin-Clavulanate or Azithromycin based on local guidelines)
• Bronchodilators (salbutamol nebulization) for breathlessness
• SpO₂ monitoring — supplemental O₂ to maintain >94%
• Sputum culture if productive cough

PRIORITY 4 — Hyperglycemia Long-Term Control

• Current oral antidiabetic agents (if any) are held during acute DKA
• Metformin contraindicated during acute illness (lactic acidosis risk)
• Transition to basal-bolus insulin regimen once DKA resolves
• HbA1c testing after stabilization — target <7% for most T2DM patients
• Dietary counseling, compliance reinforcement

PRIORITY 5 — Neuropathy (Bilateral Limb Numbness)

• Evidence of diabetic peripheral neuropathy — a complication of chronically uncontrolled T2DM
• Management: Strict glycemic control (primary)
• Symptomatic: Pregabalin (75–150 mg BD) or Duloxetine (60 mg OD) for neuropathic pain/numbness
• B12 levels to rule out coexisting B12 deficiency neuropathy (common in metformin users)
• Physiotherapy and foot care education

PRIORITY 6 — SGOT Elevation

• Recheck LFTs after metabolic stabilization
• Likely metabolic hepatopathy / NAFLD — improves with glycemic control
• Avoid hepatotoxic drugs during acute phase
• Liver ultrasound if persistently elevated

Summary Diagram of Pathophysiology

Acute Bronchitis (infection)
         ↓
Counter-regulatory hormones ↑ (cortisol, glucagon, catecholamines)
         ↓
Insulin resistance worsens → Uncontrolled T2DM → RBS 510 mg/dL
         ↓
DKA: Hyperglycemia + Ketogenesis + Metabolic Acidosis
    ├── Osmotic diuresis → Dehydration (dry tongue)
    ├── Electrolyte loss → Palpitations, anxiety
    ├── Acidosis → Kussmaul breathing → Breathlessness
    ├── Hyperosmolality → Headache
    ├── Increased myocardial demand → Lateral ST changes (LVH + ischemia)
    └── Chronic hyperglycemia → Peripheral neuropathy (bilateral numbness)

Prognosis & Key Watch-outs

1. Rule out evolving MI: Serial troponin is mandatory. The ECG changes and borderline CK-MB in a DKA patient are dangerous and can mask an acute coronary event.
2. Hypokalemia: Life-threatening during insulin therapy — monitor aggressively.
3. Cerebral edema: A rare but fatal complication of DKA management — avoid over-rapid fluid replacement, especially if headache worsens.
4. Sepsis escalation: Bronchitis in an uncontrolled diabetic can rapidly progress — watch for fever, rising CRP, worsening WBC.
5. Recheck KFT post-hydration to catch any acute tubular injury unmasked after fluid resuscitation.